MedTrace Logo

Serum 25-OH Vitamin D Modulation by Sunbed Use According to EU Guideline EN 60335-2-27

NCT01976481 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 56

Last updated 2016-08-03

No results posted yet for this study

Summary

Our study aims to clarify the impact of the use of a standard sunbed according to new EU guideline EN 60335-2-27 and possibly discount the positive effects of tanning beds. We plan to investigate the serum elevation of 25(OH)D under sunbed use, respecting the new recommendations for the exposure plan for different skin types according to EN 60335-2-27.

The use of a sunbed will be compared to a control group not using a sunbed in the observation period.

* Trial with medical device

Conditions

  • Skin Toxicity

Interventions

DEVICE

sunbed exposure

exposure to sunbed ultraviolet radiation

Sponsors & Collaborators

  • University of Zurich

    lead OTHER

Principal Investigators

  • Guenther Hofbauer, Prof MD · University Hospital Zurich, Division of Dermatology

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2014-12-31
Completion
2015-08-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01976481 on ClinicalTrials.gov